Nose drop vaccine shows promise against childhood RSV
NCT ID NCT01893554
First seen May 17, 2026 · Last updated May 21, 2026 · Updated 1 time
Summary
This study tested a single dose of a live-attenuated RSV vaccine given as nose drops to 88 children aged 4 months to 5 years. The goal was to check safety and whether the vaccine triggers an immune response. Participants included children who had and had not been infected with RSV before.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS INFECTIONS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Center for Immunization Research (CIR)
Baltimore, Maryland, 21205, United States
-
Center for Immunization Research South
Laurel, Maryland, 20708, United States
Conditions
Explore the condition pages connected to this study.